Results 201 to 210 of about 50,141 (259)

Requiem for mineralocorticoid blockade in maintenance dialysis. [PDF]

Lancet
Soomro QH, Charytan DM.
europepmc   +1 more source

Different aspects of pharmacological heart failure treatment. [PDF]

Eur Heart J Cardiovasc Pharmacother
Agewall S.
europepmc   +1 more source

7050 Effect of Spironolactone On Reducing Sugar-Induced Cellular Damage In MC3T3-E1 Osteoblastic Cells

Soo Jin Yun, Hyunji Sang, So Young Park, Kwang Sik Suh, Hyun-Sook Kim, Sang Ouk Chin   +5 more
openalex   +1 more source

Androgenic hidradenitis suppurativa onset linked to gamma secretase inhibitor. [PDF]

JAAD Case Rep
Tai H, Hill KT, Parvathaneni A, Islam Z, Cohen SR.   +4 more
europepmc   +1 more source

Comparison of Eplerenone and Spironolactone in Treatment of Patients with Congestive Heart Failure Visiting a Tertiary Hospital in North India

, 2018
Abhishek Walia
openalex   +2 more sources

Lead-induced hypertension and cognitive dysfunction: brain amyloid pathology. [PDF]

Eur J Med Res
Zhang Y, Xu Y, Song Y, Wang Y, Chen M, Ji X, Lin Y, Gu S.   +7 more
europepmc   +1 more source

Mineralocorticoid receptor antagonists reduce inflammatory signaling independent of myofiber mineralocorticoid receptor. [PDF]

Endocr Metab Sci
Lowe J, Piepho AB, Gomatam CK, Debell P, Ballinger MN, Rafael-Fortney JA.   +5 more
europepmc   +1 more source

Insulin edema in slowly progressive type 1 diabetes: improvement following adjustment of insulin therapy. [PDF]

Diabetol Int
Okamura E, Harada N, Okuno K, Yamamoto K, Murakami T, Ueda Y, Yabe D.   +6 more
europepmc   +1 more source

Spironolactone in modern cardiology: from many years of experience to the latest evidence of effectiveness (literature review)

Yu.M. Sіrenko, O.O. Torbas
openalex   +1 more source

Cardiovascular-Kidney-Metabolic Effects: Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists. [PDF]

Rev Cardiovasc Med
Bozkurt B, Januzzi JL, Bansal S.
europepmc   +1 more source